LEVOMEMS: Comparison of the effects of dobutamine and levosimendan in the current treatment of heart diseases.
Key facts
- Where
- Badalona, SpanyolországSee the site
- Phase
- 4. fázis
Where in Spanyolország
- Hospital Germans Trias i PujolBadalona, SpanyolországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Instituto De Investigacion En Ciencias De La Salud Germans Trias I Pujol
- Trial code
- EU 2024-519631-42-00
- Record updated
- 2024. december 3.
- Original description
To assess the change in the pulmonary arterial pressure and the cardiac output with levosimendan or dobutamineRead full original descriptionShow less
LEVOMEMS: Comparison of the Hemodynamic Profile of Dobutamine and Levosimendan in the Current Therapeutic Context
To assess the change in the pulmonary arterial pressure and the cardiac output with levosimendan or dobutamine
Inclusion: Age> 18 years; FEVI <35% for echocardiography in the last 6 months; Functional class NYHA> III with functional impairment despite optimized treatment of HF and diuretic with admission or decompensation treated on an outpatient basis with diuretic in the last six months that motivate the implementation of the CardioMEMS device; Signing of informed consent.
Exclusion: Hypersensitivity to the active ingredients or to any of the excipients; Creatinine clearance <20 ml / min; Presión arterial sistólica <90 mmHg; Pregnant or fertile women (who are in the period between menorrhagia and menopause) without effective contraceptive coverage, or in breastfeeding.